- Home
- UFI vs INMB Comparison
UFI vs INMB Comparison
Compare UFI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- INMB
- Stock Information
- Founded
- UFI 1969
- INMB 2015
- Country
- UFI United States
- INMB United States
- Employees
- UFI N/A
- INMB N/A
- Industry
- UFI Textiles
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- INMB Health Care
- Exchange
- UFI Nasdaq
- INMB Nasdaq
- Market Cap
- UFI N/A
- INMB 112.0M
- IPO Year
- UFI N/A
- INMB 2019
- Fundamental
- Price
- UFI $5.52
- INMB $4.40
- Analyst Decision
- UFI
- INMB Strong Buy
- Analyst Count
- UFI 0
- INMB 2
- Target Price
- UFI N/A
- INMB $21.00
- AVG Volume (30 Days)
- UFI 53.5K
- INMB 198.5K
- Earning Date
- UFI 01-29-2025
- INMB 10-31-2024
- Dividend Yield
- UFI N/A
- INMB N/A
- EPS Growth
- UFI N/A
- INMB N/A
- EPS
- UFI N/A
- INMB N/A
- Revenue
- UFI $590,737,000.00
- INMB $42,000.00
- Revenue This Year
- UFI $11.45
- INMB N/A
- Revenue Next Year
- UFI $6.84
- INMB N/A
- P/E Ratio
- UFI N/A
- INMB N/A
- Revenue Growth
- UFI 1.35
- INMB N/A
- 52 Week Low
- UFI $5.41
- INMB $4.32
- 52 Week High
- UFI $7.91
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- UFI 38.91
- INMB 37.57
- Support Level
- UFI $5.48
- INMB $4.74
- Resistance Level
- UFI $5.65
- INMB $5.16
- Average True Range (ATR)
- UFI 0.15
- INMB 0.38
- MACD
- UFI 0.04
- INMB -0.05
- Stochastic Oscillator
- UFI 32.14
- INMB 5.56
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.